The story of Viagra, and its creator copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in sales , its patent expiration created a flood of lower-priced alternatives , significantly diminishing its dominance. While specific businesses may seek to capitalize on male sexual click here dysfunction